Skip to main content

Table 2 Infectious complications of early mortality

From: Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

 

Number (%)

MDI

 

 Pneumonia

 

  Streptococcus pneumoniae

2 (7.4 %)

  Pseudomonas aeruginosa

2 (7.4 %)

  Klebsiella pneumoniae

1 (3.7 %)

  Escherichia coli

1 (3.7 %)

  Influenza A

1 (3.7 %)

  Pneumocystis jiroveci

1 (3.7 %)

 Meningoencephalitis

 

  Streptococcus pneumoniae

1 (3.7 %)

CDI

 

 Pneumonia

12 (44.4 %)

Unknown

6 (22.2 %)

  1. MDI microbiologically documented infection, CDI clinical documented infection